Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Bendamustine
Related studies linked through entity extraction aliases.
A Trial Looking at Ofatumumab for People With Chronic Lymphocytic Leukaemia Who Cannot Have More Intensive Treatment
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of Venetoclax in Combination With Bendamustine + Rituximab or Bendamustine + Obinutuzumab in Participants With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE1
Rituximab/Bendamustine + Rituximab/Cytarabine for Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Brentuximab Vedotin and Bendamustine for the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bendamustine in Acute Lymphoblastic Leukemia/Lymphoma (ALL)
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Bendamustine and Ofatumumab in Elderly Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Combination With Bendamustine/Rituximab (BR) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy Study of Bendamustine to Treat Non-Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) (Tugela )
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Trial Designed to Determine Efficacy and Safety of Bendamustine+Dexamethasone+Thalidomide in R/R MM
- Status
- COMPLETED
- Phase
- PHASE2
Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)
- Status
- COMPLETED
- Phase
- PHASE2
Bendamustine, Wkly Bortezomib, Lenalidomide and Dexamethasone for Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Refractory or Relapsed Indolent Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Navitoclax in Addition to Bendamustine and Rituximab in Patients With Relapsed Diffuse Large B-Cell Lymphoma (NAVIGATE)
- Status
- WITHDRAWN
- Phase
- PHASE2
Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2